Leap Therapeutics | SC 13G:超過5%持股股東披露文件-Samsara BioCapital, L.P.(6.4%),Samsara BioCapital GP, LLC(6.4%)等
Leap Therapeutics | 3:首次持股聲明-股東 GILEAD SCIENCES, INC.
Leap Therapeutics | SC 13G:超過5%持股股東披露文件-Gilead Sciences, Inc.(13.9%)
Leap Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(4.0%),Joseph Edelman(4.0%)等
Leap Therapeutics | 4:持股變動聲明-董事 Mashiach Nissim
Leap Therapeutics | 4:持股變動聲明-董事 Dietz Thomas John
Leap Therapeutics | 4:持股變動聲明-董事 Schilsky Richard
Leap Therapeutics | 4:持股變動聲明-高管 Granfield Christine
Leap Therapeutics | 4:持股變動聲明-高管 Baum Jason
Leap Therapeutics | 4:持股變動聲明-董事 Richard Christian M
Leap Therapeutics | 4:持股變動聲明-高管 O'Mahony John Mark
Leap Therapeutics | 4:持股變動聲明-高管 Sirard Cynthia
Leap Therapeutics | 4:持股變動聲明-董事 Martin Patricia A.
Leap Therapeutics | 4:持股變動聲明-高管 LAWLOR AUGUSTINE
Leap Therapeutics | 4:持股變動聲明-董事 LOSCALZO JOSEPH
Leap Therapeutics | 4:持股變動聲明-高管 Mirabelli Christopher
Leap Therapeutics | 4:持股變動聲明-高管 ONSI DOUGLAS E
Leap Therapeutics | 4:持股變動聲明-董事 LI WILLIAM
Leap Therapeutics | 4:持股變動聲明-董事 CAVANAUGH JAMES H
Leap Therapeutics | 4:持股變動聲明-高管 Mirabelli Christopher
暫無數據